99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole

China 99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole, Find details about China Crisaborole, Crisaborole Powder from 99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole

Model NO.
D-sung Crisaborole
Product Name
Crisaborole
Name
Crisaborole Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical;Antibiotic
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
906673-24-3
Mf
C14h10bno3
MW
251
Boiling Point
425.9±55.0 °c
Density
1.33±0.1 g/cm3
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Model NO.
D-sung Crisaborole
Product Name
Crisaborole
Name
Crisaborole Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical;Antibiotic
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
906673-24-3
Mf
C14h10bno3
MW
251
Boiling Point
425.9±55.0 °c
Density
1.33±0.1 g/cm3
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole
99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole
Product Description
99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole
Product Details

99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole
Product nameCrisaborole
AppearanceWhite powder
CAS NO.906673-24-3
MFC14H10BNO3
MW251

It is a non steroidal phosphodiesterase 4 (PDE-4) inhibitor. It shows effective activity in vivo and in vitro. It is also used as a pharmaceutical intermediate.

Application&Function

99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder CrisaboroleCrisaborole is a phosphodiesterase 4 (PDE-4) inhibitor, although its specific mechanism of action in atopic dermatitis is not known. In the US, crisaborole is indicated for topical treatment of mild to moderate atopic dermatitis in people three months of age and older. In the EU, crisaborole is indicated for treatment of mild to moderate atopic dermatitis in people two years of age and older with ≤ 40% body surface area (BSA) affected.

Specification

99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole
99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole
99% CAS 906673-24-3 An2728 Crisaborole Material Crisaborole Raw Powder Crisaborole